Ovifollin
Brand names,
Ovifollin
Analogs
Ovifollin
Brand Names Mixture
- Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
- Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)
Ovifollin
Chemical_Formula
C18H22O2
Ovifollin
RX_link
No information avaliable
Ovifollin
fda sheet
Ovifollin
msds (material safety sheet)
Ovifollin
Synthesis Reference
G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)
Ovifollin
Molecular Weight
270.366 g/mol
Ovifollin
Melting Point
254.5-256 oC
Ovifollin
H2O Solubility
3 g/100mL
Ovifollin
State
Solid
Ovifollin
LogP
4.067
Ovifollin
Dosage Forms
Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension
Ovifollin
Indication
For management of Menopausal and postmenopausal disorders
Ovifollin
Pharmacology
Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.
Ovifollin
Absorption
43%
Ovifollin
side effects and Toxicity
Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.
Ovifollin
Patient Information
Ovifollin
Organisms Affected
Humans and other mammals